T. Rowe Price Investment Management, Inc. Neogenomics Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,261,218 shares of NEO stock, worth $19.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,261,218
Previous 3,317,169
1.69%
Holding current value
$19.8 Million
Previous $31.5 Million
24.27%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$41.6 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$31.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...